DR. RADWAN AJLAN

M.D.Real-Time Hydrated
Practice Location: KANSAS CITY, KS 66160
NPI Number: 1528476389
LIFETIME INDUSTRY VALUE
$1,230
2021 – 2025 Cumulative

Conflict of Interest Analysis

Dr. AJLAN is a verified Ophthalmology, Retina Specialist practitioner based in KANSAS CITY, KS.

Between 2021 and 2025, Dr. AJLAN had an overall industry promotional and research financial footprint of $1,230 as recorded in the federal CMS Open Payments database.

  • $1,230 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
  • $0 was allocated to sponsored clinical trials and medical research activities.

Dr. AJLAN's primary funding source is GENENTECH USA, which accounts for $399 (representing 32.4% of overall industry footprint).

Data coverage: 2021 – 2025  ·  Source: CMS Open Payments  ·  CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments
Research Funding
$360$180$0$3522021$3602022$1772023$3412024$02025

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

GENENTECH USA
Rank 1
$399
32.4%
ALIMERA SCIENCES
Rank 2
$295
23.9%
REGENERON HEALTHCARE SOLUTIONS
Rank 3
$254
20.6%

General payments include consulting honoraria, promotional speaking fees, meals, travel, educational materials, and entertainment offsets.

PROMOTIONAL COUNT
Active
ESTIMATED COMPLIANCE RISK
Standard

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:
2025
2025
2024
2023
2022
2021
Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.